Phosphorylation mediates Sp1 coupled activities of proteolytic processing, desumoylation and degradation

Cell Cycle

Volumn 7, Issue 5, 2008, Pages 623-630

  Spengler, Mary L ^a   Guo, Li Wu ^a   Brattain, Michael G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Degradation; Key regulatory lysine; Phosphorylation; Proteolytic processing; Sp1; Sumoylation; Transcriptional regulation; Ubiquitinylation

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; CYCLIN A; CYCLIN DEPENDENT KINASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN KINASE C; SERINE; SUMO 1 PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING KINETICS; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; CHEMICAL MODIFICATION; DESUMOYLATION; DNA SYNTHESIS; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HOUSEKEEPING GENE; HUMAN; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 41849083427     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.5.5402     Document Type: Article

References (40)

1. Briggs MR, Kadonaga JT, Bell SP, Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 1986; 234:47-52.
2. Black AR, Black JD, Azizkhan Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001; 188:143-60.
3. Marin M, et al Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 1997; 89:619-28.
4. Li L, He S, Sun JM, Davie JR. Gene regulation by Sp1 and Sp3. Biochem Cell Biol 2004; 82:460-71.
5. Spengler ML, Brattain MG. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription. J Biol Chem 2006; 281:5567-74.
6. Freiman RN, Tjian R. Regulating the regulators: lysine modifications make their mark. Cell 2003; 112:11-7.
7. Kodadek T, Sikder D, Nalley K. Keeping transcriptional activators under control. Cell 2006; 127:261-4.
8. Rohlff C, et al Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J Biol Chem 1997; 272:21137-41.
9. Pal S, Claffey KP, Cohen HT, Mukhopadhyay D. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol Chem 1998; 273:26277-80.
10. Fojas de Borja P, et al Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. Embo J 2001; 20:5737-47.
11. Milanini Mongiat J, Pouyssegur J, Pages G. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 2002; 277:20631-9.
12. Jackson S, Gottlieb T, Hartley K. Phosphorylation of transcription factor Sp1 by the DNA-dependent protein kinase. Adv Second Messenger Phosphoprotein Res 1993; 28:279-86.
13. Zheng XL, et al Activation of apolipoprotein AI gene expression by protein kinase A and kinase C through transcription factor, Sp1. J Biol Chem 2000; 275:31747-54.
14. Hewson CA, Edbrooke MR, Johnston SL. PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 2004; 344:683-95.
15. Banchio C, Schang LM, Vance DE. Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle. J Biol Chem 2004; 279:40220-6.
16. Yang SH, Jaffray E, Hay RT, Sharrocks AD. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol Cell 2003; 12:63-74.
17. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev 2005; 15:536-41.
18. Su K, et al. An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J Biol Chem 1999; 274:15194-202.
19. Amir RE, Haecker H, Karin M, Ciechanover A. Mechanism of processing of the NFkappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase. Oncogene 2004; 23:2540-7.
20. Black AR, Jensen D, Lin SY, Azizkhan JC. Growth/cell cycle regulation of Sp1 phosphorylation. J Biol Chem 1999; 274:1207-15.
21. Udvadia AJ, Templeton DJ, Horowitz JM. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci USA 1995; 92:3953-7.
22. Frey MR, et al. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol 2000; 151:763-78.
23. Sapetschnig A, et al. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. Embo J 2002; 21:5206-15.
24. Gong L, Millas S, Maul GG, Yeh ET. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem 2000; 275:3355-9.
25. Nicolas M, Noe V, Jensen KB, Ciudad CJ. Cloning and characterization of the 5′-flanking region of the human transcription factor Sp1 gene. J Biol Chem 2001; 276:22126-32.
26. Xiao G, et al Retroviral oncoprotein Tax induces processing of NFkappaB2/p100 in T cells: evidence for the involvement of IKKalpha. Embo J 2001; 20:6805-15.
27. Ammanamanchi S, Kim SJ, Sun LZ, Brattain MG. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2′-deoxycytidine. J Biol Chem 1998; 273:16527-34.
28. Tai TC, Wong DL. Protein kinase A and protein kinase C signaling pathway interaction in phenylethanolamine N-methyltransferase gene regulation. J Neurochem 2003; 85:816-29.
29. Emkey R, Kahn CR. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. II. Comparison of phorbol ester and sphingomyelinase-induced phosphorylation of ErbB2 and ErbB3. J Biol Chem 1997; 272:31182-9.
30. Alroy I, Soussan L, Seger R, Yarden Y. Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol Cell Biol 1999; 19:1961-72.
31. Hsu MC, Chang HC, Hung WC. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J Biol Chem 2006; 281:4718-25.
32. Zheng XL, et al. Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1. J Biol Chem 2001; 276:13822-9.
33. Spengler ML, et al. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. Cell Signal 2005; 17:153-66.
34. Braun H, et al Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res 2001; 29:4994-5000.
35. Lee TH, Chuang LY, Hung WC. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene 2000; 19:3766-73.
36. Qing G, Qu Z, Xiao G. Regulation of NFkappa B2 p100 processing by its cis-acting domain. J Biol Chem 2005; 280:18-27.
37. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NFkappaB activation. Mol Cell 1998; 2:233-9.
38. Lee JA, et al. Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J Biol Chem 2005; 280:28061-71.
39. Hacker H, Karin M. Is NFkappaB2/p100 a direct activator of programmed cell death? Cancer Cell 2002; 2:431-3.
40. Shi Q, et al Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 2001; 61:4143-54.